Compound details
Isomelitric acid A
| Compound ID | CDAMM02737 |
|---|---|
| Common name | Isomelitric acid A | IUPAC name | 2-[3-[3-[1-carboxy-2-(3,4-dihydroxyphenyl)ethenoxy]-4-hydroxyphenyl]prop-2-enoyloxy]-3-(3,4-dihydroxyphenyl)propanoic acid |
| Molecular formula | C27H22O12 |
| Retention time | 5.62 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 539.124 | Theoretical mz | 539.118 |
| Error | 10.25 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.5481 |
| Inchi key | HFTLCJIFEZUOCR-JKXXRSRDNA-N |
|---|---|
| Smiles | O=C(O)C(OC1=CC(C=CC(=O)OC(C(=O)O)CC2=CC=C(O)C(O)=C2)=CC=C1O)=CC3=CC=C(O)C(O)=C3 |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P22748 | CA4 | Carbonic anhydrase IV | T53378 | SEA |
| P15121 | AKR1B1 | Aldose reductase | T26623 | SwissTargetPrediction and SEA |
| P42330 | AKR1C3 | Aldo-keto-reductase family 1 member C3 | T60857 | SEA |
| P11926 | ODC1 | Ornithine decarboxylase | T60366 | SEA |
| P07101 | TH | Tyrosine 3-hydroxylase | T62390 | SEA |
| Q01650 | SLC7A5 | L-type amino acid transporter 1 (by homology) | T48330 | SEA |
| P14780 | MMP9 | Matrix metalloproteinase 9 | T54156 | SEA |
| P19838 | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | T83145 | SEA |
| P16050 | ALOX15 | Arachidonate 15-lipoxygenase | T16042 | SEA |
| P11388 | TOP2A | DNA topoisomerase II alpha | T17048 | SEA |
| Q09472 | EP300 | Histone acetyltransferase p300 | T25956 | SEA |
| P47989 | XDH | Xanthine dehydrogenase | T40954 | SEA |
| P10636 | MAPT | Microtubule-associated protein tau | T45593 | SEA |
| Q04760 | GLO1 | Glyoxalase I | T88285 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| P01100 | FOS | Proto-oncogene c-Fos | T28025 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T53378 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P22748 | CA4 |
| T53378 | DI0166 | Glaucoma | [ICD-11: 9C61] | P22748 | CA4 |
| T53378 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P22748 | CA4 |
| T26623 | DI0298 | Neuropathy | [ICD-11: 8C0Z] | P15121 | AKR1B1 |
| T26623 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P15121 | AKR1B1 |
| T60857 | DI0145 | Female pelvic pain | [ICD-11: GA34] | P42330 | AKR1C3 |
| T60366 | DI0020 | African trypanosomiasis | [ICD-11: 1F51] | P11926 | ODC1 |
| T62390 | DI0019 | Adrenomedullary hyperfunction | [ICD-11: 5A75] | P07101 | TH |
| T62390 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P07101 | TH |
| T54156 | DI0219 | Ischaemic/haemorrhagic stroke | [ICD-11: 8B20] | P14780 | MMP9 |
| T54156 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P14780 | MMP9 |
| T54156 | DI0395 | Stomach cancer | [ICD-11: 2B72] | P14780 | MMP9 |
| T54156 | DI0419 | Ulcerative colitis | [ICD-11: DD71] | P14780 | MMP9 |
| T83145 | DI0218 | Irritable bowel syndrome | [ICD-11: DD91] | P19838 | NFKB1 |
| T83145 | DI0366 | Rheumatoid arthritis | [ICD-11: FA20] | P19838 | NFKB1 |
| T17048 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P11388 | TOP2A |
| T17048 | DI0225 | Kaposi sarcoma | [ICD-11: 2B57] | P11388 | TOP2A |
| T17048 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | P11388 | TOP2A |
| T25956 | DI0346 | Prostate cancer | [ICD-11: 2C82] | Q09472 | EP300 |
| T25956 | DI0391 | Solid tumour/cancer | [ICD-11: 2A00-2F9Z] | Q09472 | EP300 |
| T40954 | DI0206 | Inborn purine/pyrimidine/nucleotide metabolism error | [ICD-11: 5C55] | P47989 | XDH |
| T40954 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P47989 | XDH |
| T45593 | DI0012 | Acute myeloid leukaemia | [ICD-11: 2A60] | P10636 | MAPT |
| T45593 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P10636 | MAPT |
| T45593 | DI0265 | Mild neurocognitive disorder | [ICD-11: 6D71] | P10636 | MAPT |
| T88285 | DI0210 | Influenza | [ICD-11: 1E30-1E32] | Q04760 | GLO1 |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |